Legal & General Group Plc Sells 9,505 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Legal & General Group Plc cut its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 3.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 282,908 shares of the company’s stock after selling 9,505 shares during the quarter. Legal & General Group Plc owned approximately 0.17% of Option Care Health worth $6,563,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Wellington Management Group LLP raised its stake in Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after purchasing an additional 8,400,208 shares in the last quarter. Norges Bank bought a new stake in shares of Option Care Health during the 4th quarter worth approximately $60,219,000. Victory Capital Management Inc. boosted its position in shares of Option Care Health by 31.1% during the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company’s stock worth $49,310,000 after acquiring an additional 503,840 shares in the last quarter. Magnetar Financial LLC increased its stake in Option Care Health by 23.1% in the fourth quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company’s stock valued at $54,534,000 after acquiring an additional 441,265 shares during the last quarter. Finally, Trexquant Investment LP bought a new stake in Option Care Health during the fourth quarter worth $10,161,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $32.09 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm’s 50-day moving average price is $33.33 and its 200-day moving average price is $28.65. The firm has a market capitalization of $5.27 billion, a P/E ratio of 26.96, a P/E/G ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Barrington Research boosted their price target on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Finally, JMP Securities reissued a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $33.00.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.